1
0
0
News
ArcherDX and Illumina Partner for Future to Co-Market CNNwww.cnn.com › business › newsfeeds › prnewswire
edition.cnn.com
· ... to patients," said Dr. Phil Febbo, Chief Medical Officer of Illumina and follow us @ArcherDXInc on Twitter, Facebook and LinkedIn.
OptimizeRx Continues Coronavirus Conversation Series with CNNwww.cnn.com › newsfeeds › globenewswire
edition.cnn.com
He will be joined by Rusty Frantz, president and CEO of NextGen, and Phil Febbo, chief medical officer and SVP of Illumina. The panel will be moderated by ...
Test aids prostate cancer treatment | Fox News
www.foxnews.com
... and previous research linking a poor response to the two drugs to the AR-V7 variant, are sufficient validation for clinical use, said Phil Febbo, ...
Dr. Phil Febbo Named to Varian Board of Directors - PR...
news.boardprospects.com
Dr. Phil Febbo Named to Varian Board of Directors
Interessen
Dr. Phil Febbo Named to Varian Board of Directors | Markets Insider
markets.businessinsider.com
· PALO ALTO, Calif., Aug. 21, PRNewswire/ -- Varian (NYSE: VAR) today announced that Phil Febbo, MD, chief medical officer (CMO) at ...
Illumina Names Dr. Phil Febbo Chief Medical Officer | Business Wire
www.businesswire.com
(NASDAQ:ILMN) announced today the appointment of Dr. Phil Febbo, a leading physician scientist, as Chief Medical Officer (CMO), starting ...
Blood Profiling Atlas in Cancer Consortium (BloodPAC) Announces...
www.prweb.com
... data-sharing, and accepted best practices,” said Phil Febbo, MD, chief medical officer of Genomic Health, Inc. “BloodPAC, in just one year, ...
Dr. Phil Febbo Named to Varian Board of Directors - PR Newswirewww.prnewswire.com › news-releases › dr-phil-feb...
www.prnewswire.com
· PRNewswire/ -- Varian (NYSE: VAR) today announced that Phil Febbo, MD, chief medical officer (CMO) at Illumina has been appointed to the ...
Business-Profile
Biographie von Phil Febbo - The Official Board
www.theofficialboard.de
Phil Febbo ist derzeit Chief Medical Officer bei Illumina.
Firmen-Mitarbeiter
Management Team
www.illumina.com
We have passionate leaders committed to sharing their vision and to living Illumina's values. They are recognized as thought leaders in the industry.
Dokumente zum Namen
Abstracts: Impact of the 17-gene Panel On Active Surveillance...
university.auanet.org
Fill this in with your information
Interrogating mTOR Inhibition in Patients with HRPC
cdmrp.army.mil
Karla Morris. – Alicia Wilkerson. – James Turnbull. – Ana Garcia-Turner. – Andrew Armstrong. – Sarah Yenser. – Nancy Major. • Laboratory. – Phil Febbo.
Wissenschaftliche Veröffentlichungen
How coronavirus mutations can track its spread—and ...www.nationalgeographic.com › ho...
www.nationalgeographic.com
... now have the ability to get samples to the lab to do shotgun sequencing,” says Phil Febbo, a physician and chief medical officer of Illumina, ...
US$ 1.4 Million for COVID-19 Surveillance in Africa - Science ...www.sciencefordemocracy.org › u...
www.sciencefordemocracy.org
... control efforts, and ultimately, help improve human health,” said Illumina's Senior Vice President and Chief Medical Officer, Dr. Phil Febbo.
Veröffentlichungen allgemein
Meeting Notes - Mark Bridge - Wiki@UCSF
wiki.library.ucsf.edu
Bob Hiatt @June; Elissa Ozanne @JeffB; Raj Dahiya @Matt (urology, va); Phil Febbo @June (haemonc elsewhere); Colin Collins @June; add ...
Video & Audio
Illumina CMO on working with China on coronavirus cure
www.cnbc.com
· Phil Febbo, Illumina chief medical officer, discusses the possibility of a coronavirus cure amid ...Dauer: 4:40Gepostet:
Artikel & Meinungen
Wikipedia: Richard Klausner - Wikipedia
Richard D. Klausner is an American scientist who served as the 11th director of the National ... "Illumina Taps Phil Febbo to Oversee Precision Medicine Strategy as CMO".
an interview with Phil Febbo, Illumina Inc. - Oncology Centralwww.oncology-central.com › unlocking-the-power-...
www.oncology-central.com
· He has been a member of the American Society for Clinical Investigation since Connect with Phil on Twitter and LinkedIn. Share ...
Record-breaking Achievement at Rady Children's Institute for ...www.justmeans.com › blog › record-breaking-achie...
www.justmeans.com
· Phil Febbo, CMO Illumina https://bit.ly/2T8eKlw. Blog. Minutes matter when a critically ill baby needs a genome-based diagnosis and the team ...
Sonstiges
The Power and Promise of Liquid Biopsies - LinkedInwww.linkedin.com › pulse › power...
www.linkedin.com
By: Dr. Phil Febbo Tumor tissue diagnostic biopsies are a critical component in cancer care.
The Complex World of Pan-Cancer Biomarkers - LinkedInwww.linkedin.com › pulse › complex-world-pan-ca...
www.linkedin.com
· Genomic biomarkers create actionable insights in treating cancer. By: Phil Febbo, M.D., Chief Medical Officer at Illumina.
PierianDx kündigt erweiterte Partnerschaft mit Illumina ...
de.finance.yahoo.com
Dec 02, · Dr. Phil Febbo, Senior Vice President und Chief Medical Officer von Illumina, sagte: „PierianDx hat seinen Einsatz für Best-in-Class-Varianten von Berichtslösungen bewiesen. Wir freuen uns, unsere Partnerschaft zu erweitern, um die für die klinische Krebsforschung optimierte Panel-Suite AmpliSeq™ einzubeziehen."
Dr Phil Febbo Named : Latest news, Breaking news headlines ...www.scoopnest.com › ...
www.scoopnest.com
Get all Latest News about Dr Phil Febbo Named, Breaking headlines and Top stories, photos & video in real time.
We asked healthcare leaders for their best career advice — and what ...finance.yahoo.com/.../asked-healthcare-leaders-best-career
finance.yahoo.com
"Everybody needs a mentor," Genomic Health chief medical officer Dr. Phil Febbo told Business Insider. Febbo spent most of his career as a ...
Illuminas Phil febbo on sequencing coronavirus and outbreaks
glorikian.com
Harry speaks with Illuminas Phil Febbo about sequencing's emerging contribution to the understanding and treatment of viral outbreaks
Genomic Leaders Collaborate to Create Australia's First National ...finance.yahoo.com › news › genomic-leaders-collab...
finance.yahoo.com
· ... pandemic and Illumina is thrilled to be an instrumental partner of this effort," Dr Phil Febbo, Illumina's Chief Medical Officer, said.
Dr. Phil Febbo appointed to Varian Medical Systems Inc. Board.
www.directorsandboards.com
Dr. Phil Febbo appointed to the Board of Directors of Varian Medical Systems Inc. He is Chief Medical Officer at Illumina.
Dr. Phil Febbo Named to Varian Board of Directors | BioSpace
www.biospace.com
Dr. Phil Febbo Named to Varian Board of Directors - read this article along with other careers information, tips and advice on BioSpace
Dr. Phil Febbo Named to Varian Board of Directors | Nasdaq
www.nasdaq.com
PALO ALTO, Calif., Aug. 21, PRNewswire/ -- Varian (NYSE: VAR) today announced that Phil Febbo, MD, chief medical officer (CMO) at ...
Illumina Names Dr. Phil Febbo Chief Medical Officer - Illumina...
www.benzinga.com
Illumina names Dr. Phil Febbo Chief Medical Officer - Brings unmatched bench-to-bedside expertise to catalyze the adoption of precision medicine. (Photo: ...
Oncotype DX® AR-V7 Nucleus Detect™ - Phil Febbo, MD - UroTodaywww.urotoday.com › imaging-center-coe-videos
www.urotoday.com
(Length of Discussion: 40 sec) Dr. Phil Febbo, chief medical officer of Genomic Health ...
Phil Febbo - Chief Medical Officer at Illumina | The Orgtheorg.com › org › illumina › org-chart › phil-febbo
theorg.com
Phil Febbo. Chief Medical Officer at Illumina. Join to edit. Join to edit. No bio yet. Roles. Chief Medical Officer. Current role. Colleagues.
Illumina Names Dr. Phil Febbo Chief Medical Officer | Canadian Insider
www.canadianinsider.com
Illumina, Inc. (NASDAQ:ILMN) announced today the appointment of Dr. Phil Febbo, a leading physician scientist, as Chief Medical Officer ...
Illumina Names Dr. Phil Febbo Chief Medical Officer | Canadian ...m.canadianinsider.com › illumina-names-dr-phil-...
m.canadianinsider.com
Illumina, Inc. (NASDAQ:ILMN) announced today the appointment of Dr. Phil Febbo, a leading physician scientist, as Chief Medical Officer (CMO), starting March ...
Illumina Names Dr. Phil Febbo Chief Medical Officer - IBO
instrumentbusinessoutlook.com
· (NASDAQ:ILMN) announced today the appointment of Dr. Phil Febbo, a leading physician scientist, as Chief Medical Officer (CMO), starting March ...
Illumina appoints Dr. Phil Febbo as Chief Medical Officer
www.pharmajournalist.com
Illumina asserted the appointment of Dr. Phil Febbo who is a Leading physician scientist, as Chief Medical Officer (CMO), starting March 26, ...
Phil Febbo sv - PMWC Precision Medicine World Conference
www.pmwcintl.com
Illumina. Dr. Phil G. Febbo is responsible for developing and executing the Company’s medical strategy to drive genomic testing into healthcare practice. Dr....
Xconomy: Illumina Picks Genomic Health's Phil Febbo for Chief Medical...
xconomy.com
· Illumina (NASDAQ: ]) has appointed Phil Febbo to serve as chief medical officer of the San Diego genomics technologies company.
llumina Appoints Dr. Phil Febbo as CMO. - Free Online Library
www.thefreelibrary.com
Free Online Library: llumina Appoints Dr. Phil Febbo as CMO. by
Verwandte Suchanfragen zu Phil Febbo
|
Personen Vorname "Phil" (5576) Name "Febbo" (41) |
sortiert nach Relevanz / Datum